Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VKORC1 | Q9BQB6 | 2/20 | 0.74 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.59 |
| ▸ | MGAM | O43451 | 4/20 | 0.59 |
| ▸ | GAA | P10253 | 4/20 | 0.59 |
| ▸ | SI | P14410 | 4/20 | 0.59 |
| ▸ | MGAM2 | Q2M2H8 | 4/20 | 0.59 |
| ▸ | NQO1 | P15559 | 1/20 | 0.58 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.57 |
| ▸ | ACHE | P22303 | 1/20 | 0.56 |
| ▸ | BACE1 | P56817 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.55 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.55 |
| ▸ | BCHE | P06276 | 1/20 | 0.54 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.53 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27489471 | 0.85 | VKORC1 (0.67) | VKORC1PTPN1MGAMGAASI | |
| SCHEMBL5309695 | 0.85 | VKORC1 (1.00) | VKORC1PTPN1MGAMGAASI | |
| SCHEMBL5309688 | 0.85 | VKORC1 (1.00) | VKORC1PTPN1MGAMGAASI | |
| SCHEMBL27442812 | 0.85 | VKORC1 (0.67) | VKORC1PTPN1MGAMGAASI | |
| SCHEMBL16768172 | 0.84 | VKORC1 (0.97) | VKORC1PTPN1MGAMGAASI | |
| SCHEMBL6272788 | 0.82 | TDP1 (0.58) | VKORC1PTPN1MGAMGAASI | |
| SCHEMBL6272791 | 0.82 | TDP1 (0.58) | VKORC1PTPN1MGAMGAASI | |
| SCHEMBL27599592 | 0.82 | VKORC1 (0.62) | VKORC1PTPN1MGAMGAASI | |
| SCHEMBL27582360 | 0.81 | VKORC1 (0.61) | VKORC1PTPN1MGAMGAASI | |
| SCHEMBL8496149 | 0.80 | TDP1 (0.60) | VKORC1PTPN1MGAMGAASI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023220281-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF COINFECTION WITH EIMERIA AND CLOSTRIDIUM | CAN TECHNOLOGIES, INC. (US) | 2023-11-16 | — | — | WO | claimed |
| US-20250311723-A1 | METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS | IMPELLO BIOSCIENCES, INC. | 2025-10-09 | — | — | US | disclosed |
| WO-2023220281-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF COINFECTION WITH EIMERIA AND CLOSTRIDIUM | CAN TECHNOLOGIES, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| US-20230200385-A1 | METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS | IMPELLO BIOSCIENCES, INC. | 2023-06-29 | — | — | US | disclosed |
| EP-4188090-A2 | METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS | Impello Biosciences, Inc. (US) | 2023-06-07 | — | — | EP | disclosed |
| US-11638427-B2 | Methods and compositions for altering secondary metabolites in plants | IMPELLO BIOSCIENCES, INC. (US) | 2023-05-02 | — | — | US | disclosed |
| US-20220079150-A1 | METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS | IMPELLO BIOSCIENCES, INC. | 2022-03-17 | — | — | US | disclosed |
| WO-2022026613-A2 | METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS | IMPELLO BIOSCIENCES, INC. (US) | 2022-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220079150-A1 | METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS | ERG28, AHCY, BROX | VKORC1 945/4885PTPN1 1452/4885MGAM 805/4885 |
| US-20250311723-A1 | METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS | ERG28, AHCY, BROX | VKORC1 945/4885PTPN1 1452/4885MGAM 805/4885 |
| US-11638427-B2 | Methods and compositions for altering secondary metabolites in plants | ERG28, AHCY, BROX | VKORC1 945/4885PTPN1 1452/4885MGAM 805/4885 |
| US-20230200385-A1 | METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS | ERG28, AHCY, BROX | VKORC1 945/4885PTPN1 1452/4885MGAM 805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.